<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31977.016</object-id><label>Table 1.</label><caption><title>Single FGWAS annotation enrichment in T2D and FG GWAS data.</title><p>For each chromatin&#160;state&#160;annotation the total number of sites and the single state FGWAS log2 Fold Enrichment (log2FE) in T2D and FG is shown.&#160;In addition, log2FE enrichment is also shown for CDS and CONS annotation. 95% Confidence Intervals (CI) for log2FE are shown in brackets and significantly enriched states are highlighted in bold (lower CI limit &gt;0). Parker enhancer states refer to enhancer states defined by <xref ref-type="bibr" rid="bib46">Parker et al., 2013</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chromatin <break/>States</th><th>Total number of states</th><th>T2D log2FE <break/>(CI)</th><th>FG log2FE <break/>(CI)</th></tr></thead><tbody><tr><td>1. Active Promoter</td><td>20 k</td><td>&#160;1.6&#160;(-0.8 to 2.7)</td><td>&#160;2.7 (0 to 4.1)</td></tr><tr><td>2. Weak Promoter</td><td>33 k</td><td>&#160;1.7 (-4.8 to 2.9)</td><td>&#160;2.7 (-0.1 to 4.2)</td></tr><tr><td>3.Transcriptional Elongation</td><td>71 k</td><td>-0.4 (-20 to 1.1)</td><td>-26.1 (-46.1 to 1.0)</td></tr><tr><td>4. Low Methylation</td><td>73 k</td><td>-1.5 (-3.1 to -0.6)</td><td>-1.7 (-4.2 to -0.3)</td></tr><tr><td>5. Closed Weak Enhancer</td><td>206 k</td><td>&#160;1.2 (-0.1 to 2)</td><td>&#160;1.7 (0 to 2.9)</td></tr><tr><td>6. Lowly-methylated Weak Enhancer</td><td>78 k</td><td>-0.5 (-20 to 1.6)</td><td>-26.7 (-46.7 to 1.6)</td></tr><tr><td>7. Open Weak Enhancer</td><td>38 k</td><td>&#160;<bold>3.4 (2.5 to 4.2)</bold></td><td>&#160;3.1 (-0.6 to 4.6)</td></tr><tr><td>8. Closed Strong Enhancer</td><td>110 k</td><td>&#160;<bold>2.7 (1.8 to 3.4)</bold></td><td>&#160;<bold>3.3 (2 to 4.4)</bold></td></tr><tr><td>9. Open Strong Enhancer</td><td>32 k</td><td>&#160;<bold>3.8 (3.1 to 4.5)</bold></td><td>&#160;<bold>4.3 (2.8 to 5.5)</bold></td></tr><tr><td>10. Genic Enhancer</td><td>39 k</td><td>&#160;<bold>2.5 (1.3 to 3.4)</bold></td><td>&#160;<bold>2.9 (0.8 to 4.3)</bold></td></tr><tr><td>11. Accessible chromatin</td><td>14 k</td><td>-25.2 (-45.2 to 2.5)</td><td>-28.4 (-48.4 to 3.7)</td></tr><tr><td>12. Insulator</td><td>31 k</td><td>&#160;0.9 (-20 to 2.6)</td><td>-0.6 (-20 to 3.6)</td></tr><tr><td>13. Heterochromatin</td><td>216 k</td><td>&#160;2.3 (-20 to 3.9)</td><td>&#160;1.8 (-1.5 to 4.0)</td></tr><tr><td>14. Polycomb Repressed</td><td>71 k</td><td>-25.5 (-45.5 to 0.9)</td><td>-33.2 (-53.2 to 1.5)</td></tr><tr><td>15. Quiescent State</td><td>1.7 k</td><td>-1.0&#160;(-2.2 to -0.1)</td><td>-28.6 (-48.6 to -0.6)</td></tr><tr><td>CDS</td><td>NA</td><td>&#160;<bold>2.6 (1.2 to 3.5)</bold></td><td>&#160;2.7 (-0.2 to 4.3)</td></tr><tr><td>CONS</td><td>NA</td><td>&#160;<bold>2.1 (1.1 to 2.9)</bold></td><td>&#160;<bold>1.9 (0.2 to 3.2)</bold></td></tr><tr><td>Parker Weak Enhancer</td><td>119 k</td><td>&#160;0.9 (-2.5 to 2.0)</td><td>-2.0 (-20.0 to 2.4)</td></tr><tr><td>Parker Strong Enhancer (all)</td><td>123 k</td><td>&#160;<bold>2.7 (2.0 to 3.3)</bold></td><td>&#160;<bold>3.1 (2.0 to 4.4)</bold></td></tr><tr><td>Parker Strong Enhancer (open)</td><td>64 k</td><td>&#160;<bold>3.1 (2.4 to 3.7)</bold></td><td>&#160;<bold>3.6 (2.3 to 4.8)</bold></td></tr><tr><td>Parker Strong Enhancer (closed)</td><td>59 k</td><td>&#160;<bold>1.9 (0.8 to 2.7)</bold></td><td>&#160;<bold>2.3 (0.5 to 3.5)</bold></td></tr></tbody></table></table-wrap>